Extracellular K + Dampens T Cell Functions: Implications for Immune Suppression in the Tumor Microenvironment
- 1 September 2019
- journal article
- research article
- Published by SAGE Publications in Bioelectricity
- Vol. 1 (3) , 169-179
Abstract
Background: Dying tumor cells release intracellular potassium (K+), raising extracellular K+ ([K+]e) in the tumor microenvironment (TME) to 40–50 mM (high-[K+]e). Here, we investigated the effect of high-[K+]e on T cell functions. Materials and Methods: Functional impacts of high-[K+]e on human T cells were determined by cellular, molecular, and imaging assays. Results: Exposure to high-[K+]e suppressed the proliferation of central memory and effector memory T cells, while T memory stem cells were unaffected. High-[K+]e inhibited T cell cytokine production and dampened antitumor cytotoxicity, by modulating the Akt signaling pathway. High-[K+]e caused significant upregulation of the immune checkpoint protein PD-1 in activated T cells. Although the number of KCa3.1 calcium-activated potassium channels expressed in T cells remained unaffected under high-[K+]e, a novel KCa3.1 activator, SKA-346, rescued T cells from high-[K+]e-mediated suppression. Conclusion: High-[K+]e represents a so far overlooked secondary checkpoint in cancer. KCa3.1 activators could overcome such “ionic-checkpoint”-mediated immunosuppression in the TME, and be administered together with known PD-1 inhibitors and other cancer therapeutics to improve outcomes.Keywords
This publication has 39 references indexed in Scilit:
- Development of a QPatch Automated Electrophysiology Assay for Identifying KCa3.1 Inhibitors and ActivatorsASSAY and Drug Development Technologies, 2013
- Metabolic pathways in T cell fate and functionTrends in Immunology, 2012
- Tumor Immune EvasionScience, 2010
- The functional network of ion channels in T lymphocytesImmunological Reviews, 2009
- Akt-dependent and -independent mechanisms of mTOR regulation in cancerCellular Signalling, 2009
- Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a New Activator of KCa2 and KCa3.1 Potassium Channels, Potentiates the Endothelium-Derived Hyperpolarizing Factor Response and Lowers Blood PressureMolecular Pharmacology, 2009
- The tumor microenvironment and its role in promoting tumor growthOncogene, 2008
- T Cell Receptor–MHC Interactions up CloseCell, 2001
- Up-regulation of the IKCa1 Potassium Channel during T-cell ActivationJournal of Biological Chemistry, 2000
- Potassium physiologyThe American Journal of Medicine, 1986